Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Clinical Drug Investigation|March 5, 2020
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple SclerosisLorenzo G Mantovani, Paolo Cozzolino, Paolo A Cortesi, et al.
Plos One|July 12, 2021
The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studiesPietro Ferrara, Danilo Di Laura, Paolo A Cortesi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 28, 2022
Multiple Sclerosis Progressive Courses: A Clinical Cohort Long-Term Disability Progression StudyPaolo A Cortesi, Carla Fornari, Ruggero Capra, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 30, 2016
Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia ASergio Iannazzo, Paolo A Cortesi, Roberto Crea, et al.
Pharmacoeconomics|November 25, 2017
Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future DirectionsPaolo A Cortesi, Lucia S D'Angiolella, Alessandra Lafranconi, et al.
Clinical and Experimental Rheumatology|October 18, 2012
A systematic literature review of the economic impact of ankylosing spondylitisIlaria Palla, Leopoldo Trieste, Chiara Tani, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritisPaolo A Cortesi, Luciana Scalone, Lucia D'Angiolella, et al.
Pageof 4